Home›Stock Screener›Arvee Laboratories

Arvee Laboratories Share Price Today | Stock Price & Arvee Laboratories Share Screener

ARVEE Specialty Chemicals
Live Share Price NSE
₹209.39
▼ -5.93 (-2.75%)
2026-10-05 00:00:00

As of October 5, 2026, the live Arvee Laboratories share price (NSE: ARVEE) is ₹209.39, down 2.75% from the previous close, with shares trading between ₹206.35 and ₹229.79 in today's trading session, and a 52-week range of ₹133.86–₹290.78. Check ARVEE 52-week performance for the annual price range and momentum. Use the Arvee Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Arvee Laboratories opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹42 and net income of ₹4, with EBITDA of ₹6, an operating margin of 11.0% and a profit margin of 9.5%.

Arvee Laboratories Market Cap ₹248.13 Cr.
ARVEE P/E Ratio (TTM) 63.27
Arvee Laboratories P/B Ratio 7.59
EPS (TTM) ₹2.29
Dividend Yield -
Debt to Equity 0.03
ARVEE 52 Week High ₹290.78
Arvee Laboratories 52 Week Low ₹133.86
Operating Margin 11.00%
Profit Margin 9.52%
ARVEE Revenue (TTM) ₹42.00
EBITDA ₹6.00
Net Income ₹4.00
Total Assets ₹43.00
Total Equity ₹34.00

Arvee Laboratories Share Price Chart

Track the current stock price of Arvee Laboratories with an interactive chart. Analyse ARVEE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Arvee Laboratories stock quote in one place.

The quote of ₹209.39 sits between the 52-week low of ₹133.86 and the 52-week high of ₹290.78, and the latest session moved -2.75% from the previous close.

Arvee Laboratories Company Profile - Fundamental Screener

Screen Arvee Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ARVEE shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Chemicals sector and the Specialty Chemicals industry, and it trades under ISIN INE006Z01016.

Company Details

Classification

Sector Chemicals
Industry Specialty Chemicals
Sub-Sector Specialty Chemicals
Segment E

Identifiers and Leadership

ISIN INE006Z01016

Arvee Laboratories Balance Sheet Screener

Screen ARVEE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹43, up from ₹38 in 2025.

Latest statistics put total assets at ₹43 and shareholder funds at ₹34, with a leverage ratio of 0.03.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 43 38 38 39 39 41 34 37 44 36
Current Assets 25 20 17 22 24 26 18 21 27 19
Fixed Assets 17 15 13 13 14 14 13 13 15 17

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 2 3 2 2 1 1 2 4 9 17
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 34 31 29 28 24 21 19 17 14 4
Share Capital 11 11 11 11 11 11 6 6 6 4
Reserves & Surplus 23 20 18 17 13 10 13 11 9 0

Arvee Laboratories Income Statement Screener - Profit & Revenue Analysis

Screen Arvee Laboratories income statement and profit fundamentals. Analyze ARVEE quarterly results. Arvee Laboratories reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹42 and net profit was ₹4, equal to earnings per unit of ₹3.70, at an operating margin of 11%.

In that period expenses were ₹36, interest cost ₹0 and tax ₹1. The next period listed, 2026-March, shows revenue of ₹32 and net profit of ₹3.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Revenue and Expenses

Revenue 42 32 39 31 63 41 48 46 55 48 35
Expenses 36 28 35 27 54 35 41 39 49 41 29

Operating Costs and Margins

EBITDA 6 4 4 4 9 6 7 6 7 7 6
Operating Profit % 11.00% 10.00% 9.00% 10.00% 12.00% 14.00% 13.00% 13.00% 11.00% 15.00% 17.00%
Depreciation 1 1 1 2 2 2 2 2 2 2 2
Interest 0 0 0 0 0 0 1 1 2 3 4

Profit and Earnings

Profit Before Tax 5 2 3 2 6 3 4 3 3 2 1
Tax 1 0 1 1 2 1 1 1 0 1 -1
Net Profit 4 3 2 1 4 3 3 2 2 1 2
EPS 3.70 2.29 1.95 0.95 3.74 2.34 2.43 4.17 4.11 2.58 3.83

Arvee Laboratories Cash Flow Screener - Liquidity Fundamentals

Screen ARVEE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹0.

Over the same period, investing activities provided ₹1 and financing activities provided ₹0.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 0 0 4 3 1 2 10 10 6 4
Investing Activities 1 -1 -2 -1 0 -1 -3 -3 -1 -1

Financing and Net Cash

Financing Activities 0 0 0 -2 -6 5 -10 -5 -4 -3
Net Cash Flow 0 -2 1 -1 -5 6 -3 2 1 0

Arvee Laboratories Shareholding Pattern Screener

See Arvee Laboratories shareholding pattern with promoter, FII, and DII holdings. Check Arvee Laboratories promoter holding and ownership changes for ARVEE on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jun, promoters held 73.50%, foreign institutions 0.00%, domestic institutions 0.00% and the public 26.16%, spread across 1,596 shareholders.

The shareholder count was 1,596 in 2026-Jun, compared with 1,638 in 2026-Mar.

Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept

Promoter Holding

Promoter Holding 73.50% 73.50% 73.50% 73.50% 73.50% 73.50% 73.50% 73.50%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 26.16% 26.21% 26.25% 26.19% 26.31% 26.33% 26.35% 26.34%
Other Holding 0.33% 0.28% 0.25% 0.31% 0.19% 0.17% 0.15% 0.16%
Shareholder Count 1,596 1,638 1,861 1,505 1,505 1,576 1,623 1,416

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Arvee Laboratories. Arvee Laboratories dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Arvee Laboratories.

Arvee Laboratories Stock Index Membership - Nifty & Sensex

See which indices include Arvee Laboratories stock. Check ARVEE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Arvee Laboratories is not part of any tracked indices.
Only major market indices are tracked in our system.

Arvee Laboratories Market Events Screener - Corporate Actions

Get Arvee Laboratories corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Arvee Laboratories stock events that may affect ARVEE share price, along with derivatives, futures and options activity and sector gainers.

10 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated August 7, 2026, with a record date of August 7, 2026.

It is followed by Quarterly Result Announcement dated May 19, 2026 and Quarterly Result Announcement dated February 13, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-08-07 2026-08-07 Quarterly Result Announcement NA 1.36%
2026-05-19 2026-05-19 Quarterly Result Announcement NA -7.50%
2026-02-13 2026-02-13 Quarterly Result Announcement NA -4.04%
2025-11-14 2025-11-14 Quarterly Result Announcement NA 5.71%
2025-08-12 2025-08-12 Quarterly Result Announcement NA -5.54%
2025-05-09 2025-05-09 Quarterly Result Announcement NA 1.32%
2025-02-12 2025-02-12 Quarterly Result Announcement NA -3.76%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -7.87%
2024-09-28 2024-09-28 Annual General Meeting NA 3.49%
2020-10-13 2020-10-14 Bonus 1:1 10.01%

Arvee Laboratories Competitors Screener - Peer Stocks Comparison

Screen ARVEE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Pidilite Industries 149,130 55.96 14,867 11.05% 2,471 29.61
SRF 73,291 33.38 15,894 7.20% 1,835 41.26
Gujarat Fluorochemicals 48,392 80.84 5,126 5.63% 574 39.62
Navin Fluorine International 42,291 53.50 3,379 41.21% 664 45.13
Himadri Speciality Chemical 34,200 41.86 4,832 3.60% 755 49.97
Aether Industries 22,554 98.85 1,181 34.17% 220 56.48
Deepak Nitrite 20,865 26.53 7,947 -5.01% 551 32.53
Atul 17,416 21.74 6,476 13.77% 689 30.86
Aarti Industries 17,249 32.20 8,291 13.78% 419 40.60
Fine Organic Industries 15,712 35.88 2,483 4.89% 417 48.79

Arvee Laboratories Company Announcements - News & Reports Screener

Screen ARVEE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

19 recent announcements are listed, the latest dated September 15, 2026.

The next most recent announcements are dated September 9, 2026 and August 7, 2026.

Date Update Actions
2026-09-15 Trading Window -
2026-09-09 Cessation -
2026-08-07 Outcome of Board Meeting -
2026-08-04 Corrigendum -
2026-06-27 Trading Window -
2026-06-15 Disclosure under SEBI Takeover Regulations -
2026-05-19 Outcome of Board Meeting -
2026-04-15 Price movement -
2026-04-13 Price movement -
2026-03-27 Trading Window -
2026-03-06 Price movement -
2026-02-13 Outcome of Board Meeting -
2026-02-13 Outcome of Board Meeting -
2026-02-09 Corrigendum -
2025-12-30 Trading Window -
2025-12-24 Price movement -
2025-12-19 Price movement -
2025-11-14 Outcome of Board Meeting -
2025-09-24 Shareholders meeting -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹209.39, within a 52-week range of ₹133.86 to ₹290.78. The P/E ratio is 63.27 and the P/B ratio is 7.59, with earnings per unit of ₹2.29. Market capitalisation stands at ₹248.13 Cr. The company operates in the Chemicals sector, in the Specialty Chemicals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 11 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.